StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)

Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –

Harmony Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Harmony Biosciences's profit margin for the twelve months ending Jun 30, 2026 was 18.9%. For fiscal 2025 it was 18.3%, against 20.4% the year before. The highest annual figure on record is 41.4% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202518.3%−2.1
FY2024Dec 31, 202420.4%−1.8
FY2023Dec 31, 202322.1%−19.3
FY2022Dec 31, 202241.4%+30.1
FY2021Dec 31, 202111.3%+34.5
FY2020Dec 31, 2020-23.1%+2511.9
FY2019Dec 31, 2019-2535.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202628.9%+9.0
Q1 FY2026Mar 31, 202615.1%−9.6
Q4 FY2025Dec 31, 20259.2%−15.4
Q3 FY2025Sep 30, 202521.2%−3.5
Q2 FY2025Jun 30, 202519.8%+13.1
Q1 FY2025Mar 31, 202524.7%−0.1
Q4 FY2024Dec 31, 202424.6%+8.8
Q3 FY2024Sep 30, 202424.8%+0.8
Q2 FY2024Jun 30, 20246.7%−18.8
Q1 FY2024Mar 31, 202424.8%+0.0
Q4 FY2023Dec 31, 202315.8%−22.0
Q3 FY2023Sep 30, 202324.0%−51.0
Q2 FY2023Jun 30, 202325.6%+3.6
Q1 FY2023Mar 31, 202324.8%−0.4
Q4 FY2022Dec 31, 202237.8%+12.9
Q3 FY2022Sep 30, 202275.0%+86.9
Q2 FY2022Jun 30, 202222.0%+2.9
Q1 FY2022Mar 31, 202225.2%+12.8
Q4 FY2021Dec 31, 202124.9%+25.3
Q3 FY2021Sep 30, 2021-11.9%−16.1
Q2 FY2021Jun 30, 202119.1%+19.2
Q1 FY2021Mar 31, 202112.4%+207.0
Q4 FY2020Dec 31, 2020-0.4%–
Q3 FY2020Sep 30, 20204.2%–
Q2 FY2020Jun 30, 2020-0.1%–
Q1 FY2020Mar 31, 2020-194.7%–

More Harmony Biosciences figures

See a number that looks wrong?